Copyright
©The Author(s) 2024.
World J Exp Med. Mar 20, 2024; 14(1): 87202
Published online Mar 20, 2024. doi: 10.5493/wjem.v14.i1.87202
Published online Mar 20, 2024. doi: 10.5493/wjem.v14.i1.87202
Known functions | Metabolism of drugs and toxins (e.g., succinylcholine, carbamates, glucoalkaloids) | |
Affected by dietary fats | ||
Influences the expression of metabolic syndrome, via action on lipids | ||
Associations and predictors of outcomes in disease states | Nutritional status | |
Hepatic disorders | ||
Cardiovascular disease | Acute coronary syndrome | |
Acute myocardial infarction | ||
Injuries to brain and cerebrovascular and disease | Ischemic brain stroke | |
Traumatic brain injury | ||
Alzheimer’s disease | Predisposition | |
Onset | ||
Response to anticholinesterase medications | ||
Pre-eclampsia | ||
Inflammatory and infections | Sepsis | |
HIV infection | ||
Hansen’s disease | ||
Other conditions | Wilsons disease | |
Chronic obstructive pulmonary disease |
Follow up of asymptomatic individuals for any protective or predictive role in cardiovascular disease and Alzheimer’s disease |
Production from transgenic sources as a pharmacologic agent |
Potential drug target |
- Citation: Sridhar GR, Gumpeny L. Emerging significance of butyrylcholinesterase. World J Exp Med 2024; 14(1): 87202
- URL: https://www.wjgnet.com/2220-315x/full/v14/i1/87202.htm
- DOI: https://dx.doi.org/10.5493/wjem.v14.i1.87202